Processing and reactivity of T cell epitopes containing two cysteine residues from hen egg-white lysozyme (HEL74-90)

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 1775-1782

  Kang, Hee Kap ^a   Mikszta, John A ^a,d   Deng, Hongkui ^b,e   Sercarz, Eli E ^b,f   Jensen, Peter E ^c   Kim, Byung S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Becton Dickinson Technologies   (United States)

^e Ag Express Inc   (United States)

^f LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; EGG WHITE; EPITOPE; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BINDING COMPETITION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; INTERNALIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034651697     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.1775     Document Type: Article

References (54)

1. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
2. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
3. Chicz, R. M., R. G. Urban, W. S. Lane, I. C. Gorga, L. J. Stern, D. A. Vignali, and J. L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764.
4. k. Prof. Natl. Acad. Sci. USA 89:7380.
5. Rudensky, A., P. Preston-Hurlburt, B K. al-Ramadi, J. Rothbard, and C. A. Janeway, Jr. 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359:429.
6. Vignali, D. A., R. G. Urban, R. M. Chicz, and J. L. Strominger. 1993. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur. J. Immunol. 23:1602.
7. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215.
8. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
9. Allen, P. M., and E. R. Unanue. 1984. Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J. Immunol. 132:1077.
10. Streicher, H. Z., I. J. Berkower, M. Busch, F. R. Gurd, and J. A. Berzofsky. 1984. Antigen conformation determines processing requirements for T-cell activation. Proc. Natl. Acad. Sci. USA 81:6831.
11. Regnier-Vigouroux, A., M. el Ayeb, M. L. Defendini, C. Granier, and M. Pierres. 1988. Processing by accessory cells for presentation to murine T cells of apamin, a disulfide-bonded 18 amino acid peptide. J. Immunol. 140:1069.
12. Jang, Y. S., K. H. Lim, and B. S. Kim. 1991. Analysis of T cell reactivities to phosphorylcholine-conjugated hen egg lysozyme in C57BL/6 mice: hapten-conjugate specificity reflects an altered expression of a major carrier epitope. Eur. J. Immunol. 21:1303.
13. Sette, A., L. Adorini, S. M. Colon, S. Buus, and H. M. Grey. 1989. Capacity of intact proteins to bind to MHC class II molecules. J. Immunol. 143:1265.
14. Jensen, P. E. 1993. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J. Immunol. 150:3347.
15. Glimcher, L. H., J. A. Schroer, C. Chan, and E. M. Shevach. 1983. Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation. J. Immunol. 131:2868.
16. Naquet, P., J. Ellis, B. Singh, R. S. Hodges, and T. L. Delovitch. 1987. Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells. J. Immunol. 139:1955.
17. Lee, P., G. R. Matsueda, and P. M. Allen. 1988. T cell recognition of fibrinogen: a determinant on the A α-chain does not require processing. J. Immunol. 140: 1063.
18. Atassi, M. Z., G. S. Bixler, Jr., and T. Yokoi. 1989. Conformation-dependent recognition of a protein by T cells requires presentation without processing. Biochem. J. 259:731.
19. Manca, F., V. Dessi, N. Shastri, A. Oki, M. Kaplan, J. Clarke, A. Miller, and E. E. Sercarz. 1994. Isolation of lysozyme-specific T cell clones that discriminate between native and denatured antigen. Cell. Immunol. 154:420.
20. Runnels, H. A., D. A. Weber, J. C. Moore, L. E. Weslerman, and P. E. Jensen. 1997. Intact proteins can bind to class II histocompatibility molecules with high affinity. Mol. Immunol. 34:471.
21. Jang, Y. S., J. A. Mikszta, and B. S. Kim. 1994. T cell epitope recognition involved in the low-responsiveness to a region of hen egg lysozyme (46-61) in C57BL/6 mice. Mol. Immunol. 31:803.
22. Mikszta, J. A., Y. S. Jang, and B. S. Kim. 1997. Role of a C-terminal residue of an immunodominant epitope in T cell activation and repertoire diversity. J. Immunol. 158:127.
23. Shastri, N., A. Miller, and E. E. Sercarz. 1986. Amino acid residues distinct from the determinant region can profoundly affect activation of T cell clones by related antigens. J. Immunol. 136:371.
24. Shastri, N., G. Gammon, S. Horvath, A. Miller, and E. E. Sercarz. 1986. The choice between two distinct T cell determinants within a 23-amino acid region of lysozyme depends on their structural context. J. Immunol. 137:911.
25. Phillips, D. C. 1974. Crystallographic studies of lysozyme and its interactions with inhibitors and substrates. In Lysozyme. E. F. Osserman, R. E.Canfield, S. Beychok, eds. Academic Press, New York, p. 9.
26. Kim, B. S., and Y. S. Jang. 1992. Constraints in antigen processing result in unresponsiveness to a T cell epitope of hen egg lysozyme in C57BL/6 mice. Eur. J. Immunol. 22:775.
27. Wolfe, H. R., and R. R. Wilk. 1989. The RaMPS system: simplified peptide synthesis for life science researchers. Pept. Res. 2:352.
28. Inoue, A., Y. K. Choe, and B. S. Kim. 1994. Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J. Virol. 68:3324.
29. Lee, C. L., and M. Z. Atassi. 1973. Conformation and immunochemistry of methylated and carboxymethylated derivatives of lysozyme. Biochemistry 12:2690.
30. Shastri, N., A. Oki, A. Miller, and E. E. Sercarz. 1985. Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins: implications for the mechanisms underlying major histocompatibility complex-restricted antigen recognition and clonal deletion models of immune response gene defects. J. Exp. Med. 162:332.
31. Gammon, G., J. Klotz, D. Ando, and E. E. Sercarz. 1990. The T cell repertoire to a multideterminant antigen: clonal heterogeneity of the T cell response, variation between syngeneic individuals, and in vitro selection of T cell specificities. J. Immunol. 144:1571.
32. Gillis, S., and K. A. Smith. 1977. Long term culture of tumour-specific cytotoxic T cells. Nature 268:154.
33. Kappler, J. W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198.
34. Allen, P. M., G. R. Matsueda, R. J. Evans, J. B. Dunbar, Jr., G. R. Marshall, and E. R. Unanue. 1987. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature 327:713.
35. d class II histocompatibility molecules. Mol. Immunol. 34:145.
36. Ziegler, H. K., and E. R. Unanue. 1982. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc. Natl. Acad. Sci. USA 79:175.
37. Buus, S., and O. Werdelin. 1986. A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells. J. Immunol. 136:452.
38. Takahashi, H., K. B. Cease, and J. A. Berzofsky. 1989. Identification of proteases that process distinct epitopes on the same protein. J. Immunol. 142:2221.
39. Jensen, P. E. 1991. Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant. J. Exp. Med. 174:1121.
40. Mikszta, J. A., and B. S. Kim. 1996. Conversion of low antibody responders into high responders by up-regulating the T cell response to a selective epitope. J. Immunol. 157:2883.
41. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stem, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
42. Nelson, C. A., I. Vidavsky, N. J. Viner, M. L. Gross, and E. R. Unanue. 1997. Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc. Natl. Acad Sci. USA 94:628.
43. Chain, B. M., G. Bou-Gharios, and I. Olsen. 1989. Endopeptidase activities associated with the plasma membrane compartment of an antigen-presenting B cell. Clin. Exp. Immunol. 75:87.
44. Larsen, S. L., L. Ostergaard, S. Buus, and A. Stryhn. 1996. T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. J. Exp. Med. 184:183.
45. Collins, D. S., E. R. Unanue, and C. V. Harding. 1991. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J. Immunol. 147:4054.
46. Shen, W. C., H. J. Ryser, and L. LaManna. 1985. Disulfide spacer between methotrexate and poly(D-lysine): a probe for exploring the reductive process in endocytosis. J. Biol. Chem. 260:10905.
47. Feener, E. P., W. C. Shen, and H. J. Ryser. 1990. Cleavage of disulfide bonds in endocytosed macromolecules, A processing not associated with lysosomes or endosomes. J. Biol. Chem. 265:18780.
48. Harding, C. V., D. S. Collins, J. W. Slot, H. J. Geuze, and E. R. Unanue. 1991. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 64:393.
49. Gammon, G., N. Shastri, J. Cogswell, S. Wilbur, S. Sadegh-Nasseri, U. Krzych, A. Miller, and E. Sercarz. 1987. The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol. Rev. 98:53.
50. Adorini, L., E. Appella, G. Doria, and Z. A. Nagy. 1988. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 168:2091.
51. Buus, S., A. Sette, S. M. Colon, C. Miles, and H. M. Grey. 1987. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235:1353.
52. Schaeffer, E. B., A. Sette, D. L. Johnson, M. C. Bekoff, J. A. Smith, H. M. Grey, and S. Buus. 1989. Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses. Proc. Natl. Acad. Sci. USA 86:4649.
53. Nikcevich, K. M., D. Kopielski, and A. Finnegan. 1994. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo. J. Immunol. 153:1011.
54. Monji, T., and D. Pious. 1997. Exogenously provided peptides fail to complex with intracellular class II molecules for presentation by antigen-presenting cells. J. Immunol. 158:3155.